This is the authors' abstract. We don't add key points for this paper.
In this review, we describe the in vitro tools currently used to identify when a lipid-based formulation has the potential to deliver a poorly water-soluble drug via the oral route. We describe the extent to which these tools reflect the in vivo performance of the formulation and, more importantly, we present strategies that we foresee will improve the in vitro-in vivo correlations. We also present emerging computational methods that are likely to allow large parts of the formulation development to be carried out in the computer rather than in the test tube. We suggest that these computational tools will also improve the mechanistic understanding of in vivo formulation performance in the complex and dynamic environment of the gut.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Alskär et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: